Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune neuropathies in childhood

J T Sladky1

  • 1Emory University School of Medicine, Atlanta, GA 30322, USA.

Bailliere'S Clinical Neurology
|March 1, 1996
PubMed
Summary

Immune-mediated disorders cause many childhood peripheral neuropathies, with Guillain-Barré syndrome (GBS) being the most common. While treatments like plasmapheresis show promise for pediatric GBS, more research is needed for other immune neuropathies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS.

Neurology·2007
Same author

Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Neurology·2003
Same author

Teaching in the field: the model of a one-day trip to an outreach clinic.

Seminars in neurology·2002
Same author

Histopathological features of peripheral nerve and muscle in mitochondrial disease.

Seminars in neurology·2001
Same author

Abnormal fatty acid metabolism in childhood spinal muscular atrophy.

Annals of neurology·1999
Same author

A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene.

Neuromuscular disorders : NMD·1995

Area of Science:

  • Pediatric Neurology
  • Immunology
  • Demyelinating Diseases

Background:

  • Immune-mediated disorders are a leading cause of peripheral neuropathies in children, unlike in older populations.
  • Guillain-Barré syndrome (GBS) is the most frequent diagnosis, accounting for 25% of pediatric sensorimotor neuropathies.
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is the second most common cause of chronic sensorimotor neuropathy in children.

Purpose of the Study:

  • To review the epidemiology and clinical features of immune-mediated peripheral neuropathies in children.
  • To discuss current treatment modalities and prognosis for pediatric GBS and CIDP.
  • To highlight the relative rarity of other immune-mediated neuropathies and HIV-associated neuropathies in this age group.

Main Methods:

  • Retrospective analysis of pediatric cases with peripheral neuropathy.
  • Review of clinical presentations, diagnostic entities, and treatment outcomes.
  • Comparison of pediatric findings with adult populations.

Main Results:

  • GBS is the most common immune-mediated neuropathy in children, with a generally better prognosis than in adults.
  • Plasmapheresis appears effective for GBS recovery in children, though data is limited.
  • CIDP presents variably in children and has a good prognosis, but some cases result in significant disability or side effects.

Conclusions:

  • Immune-mediated neuropathies, particularly GBS and CIDP, are significant causes of peripheral nerve disorders in children.
  • Treatment strategies for pediatric GBS are evolving, with plasmapheresis showing potential.
  • Further research is needed to establish optimal management for pediatric immune-mediated neuropathies, especially regarding intravenous immunoglobulin (IVIG) for GBS.

Related Experiment Videos